Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, ...

A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...

With it exclusive window on cholesterol drug Lipitor long closed, Pfizer is looking to the post-Lipitor world. WSJ's Spencer Jakab visits Mean Street to make the case that the company's future is ...

NEW YORK (AP) -- Pfizer Inc. won a crucial court ruling Friday that will allow it to exclusively sell the top-selling drug worldwide, the cholesterol-lowering drug Lipitor, until 2011. Shares of ...

WASHINGTON -- Pfizer Inc. announced Monday it is pulling its Lipitor advertisements that feature the inventor of the artificial heart whose endorsement came under congressional fire earlier this year.

Pfizer (NYSE: PFE) is no stranger to income investors. The drugmaker, famous for treatments including Lipitor, Viagra, and Zoloft, has now increased its dividend payout for 16 consecutive years. And ...

The $68 billion acquisition will solidify Pfizer’s standing as the top-selling drugmaker. Bottles of Pfizer’s Lipitor, left, and Wyeth’s Effexor are shown. Shareholders of Wyeth voted overwhelmingly ...

Pfizer Inc is urging the U.S. Supreme Court to allow it to remove lawsuits by about 4,800 women who claim they developed diabetes as a result of taking Lipitor, its blockbuster anti-cholesterol drug, ...

Lipitor is so valuable that Pfizer is practically paying people to keep taking its blockbuster cholesterol medicine after generic competition hits the U.S. market this week.